Gross Margin: 43.89%
Is the gross margin high or low?
The gross margin of 43.89% is in line with its 5-year average of 43.78%, around the middle of its 5-year range (40.13%–47.21%).
As of Friday, June 26, 2026. 0.43% below its 12-month average of 44.08%.
STE Gross Margin
Reported quarterly gross margin; no daily interpolation.
STE Average Gross Margin Chart
STE Current vs Average Gross Margin Chart
STE Gross Margin Metrics
GROSS MARGIN
43.89%
GROSS MARGIN AVG TTM
44.08%
GROSS MARGIN AVG 3Y
43.97%
GROSS MARGIN AVG 5Y
43.99%
GROSS MARGIN AVG 10Y
43.15%
GROSS MARGIN AVG 15Y
42.18%
GROSS MARGIN AVG 20Y
42.00%
CURRENT VS TTM AVG
-0.43%
CURRENT VS 3Y AVG
-0.19%
CURRENT VS 5Y AVG
-0.24%
CURRENT VS 10Y AVG
+1.71%
CURRENT VS 15Y AVG
+4.05%
CURRENT VS 20Y AVG
+4.48%
STE Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $21.00B | 43.89% | 44.08% | 43.97% | 43.99% |
| Labcorp Holdings Inc. (LH)vs › | $22.10B | 27.79% | 27.30% | 28.39% | 31.16% |
| Incyte Corporation (INCY)vs › | $22.73B | 92.48% | 92.70% | 93.10% | 93.74% |
| Viatris Inc. (VTRS)vs › | $19.02B | 34.40% | 36.61% | 38.73% | 36.31% |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 86.58% | 88.58% | 89.63% | 90.66% |
| BioNTech SE (BNTX)vs › | $23.07B | 73.26% | 78.98% | 81.24% | 82.89% |
| Quest Diagnostics Incorporated (DGX)vs › | $23.08B | 33.23% | 32.39% | 33.17% | 35.04% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.01B | 61.62% | 66.54% | 68.95% | 69.55% |
| Waters Corporation (WAT)vs › | $24.41B | 55.02% | 58.60% | 58.69% | 58.45% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.79B | 36.24% | 35.27% | 37.10% | 37.60% |
Gross Margin Analysis
Gross Margin
43.9%
(Revenue - COGS) / Revenue
Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gross Margin FAQ
- What is the gross margin for STERIS plc (STE)?
- The gross margin for STE stock is 43.89%.
- Is STERIS plc's gross margin high or low?
- The gross margin of 43.89% is in line with its 5-year average of 43.78%, around the middle of its 5-year range (40.13%–47.21%).
- What is the TTM average gross margin for STERIS plc (STE)?
- The TTM average gross margin for STE stock is 44.08%.
- What is the 3Y average gross margin for STERIS plc (STE)?
- The 3Y average gross margin for STE stock is 43.97%.
- What is the 5Y average gross margin for STERIS plc (STE)?
- The 5Y average gross margin for STE stock is 43.99%.
- What is the 10Y average gross margin for STERIS plc (STE)?
- The 10Y average gross margin for STE stock is 43.15%.
- What is the 15Y average gross margin for STERIS plc (STE)?
- The 15Y average gross margin for STE stock is 42.18%.
- What is the 20Y average gross margin for STERIS plc (STE)?
- The 20Y average gross margin for STE stock is 42.00%.
STE Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 43.89% |
| 2025-12-31 | 43.81% |
| 2025-09-30 | 44.23% |
| 2025-06-30 | 45.14% |
| 2025-03-31 | 43.31% |
| 2024-12-31 | 44.53% |
| 2024-09-30 | 43.55% |
| 2024-06-30 | 44.74% |
| 2024-03-31 | 40.19% |
| 2023-12-31 | 43.15% |
| 2023-09-30 | 44.11% |
| 2023-06-30 | 44.70% |
| 2023-03-31 | 42.46% |
| 2022-12-31 | 42.89% |
| 2022-09-30 | 44.34% |
| 2022-06-30 | 44.77% |
| 2022-03-31 | 47.21% |
| 2021-12-31 | 44.51% |
| 2021-09-30 | 40.13% |
| 2021-06-30 | 44.02% |
| 2021-03-31 | 43.69% |
| 2020-12-31 | 42.76% |
| 2020-09-30 | 43.65% |
| 2020-06-30 | 42.96% |
| 2020-03-31 | 44.24% |
| 2019-12-31 | 42.80% |
| 2019-09-30 | 43.25% |
| 2019-06-30 | 43.89% |
| 2019-03-31 | 43.57% |
| 2018-12-31 | 41.22% |
| 2018-09-30 | 41.93% |
| 2018-06-30 | 42.12% |
| 2018-03-31 | 40.89% |
| 2017-12-31 | 42.03% |
| 2017-09-30 | 42.01% |
| 2017-06-30 | 42.07% |
| 2017-03-31 | 41.12% |
| 2016-12-31 | 39.83% |
| 2016-09-30 | 38.35% |
| 2016-06-30 | 37.59% |
| 2016-03-31 | 38.23% |
| 2015-12-31 | 38.50% |
| 2015-09-30 | 42.73% |
| 2015-06-30 | 41.85% |
| 2015-03-31 | 42.47% |
| 2014-12-31 | 41.66% |
| 2014-09-30 | 41.92% |
| 2014-06-30 | 41.22% |
| 2014-03-31 | 39.65% |
| 2013-12-31 | 40.38% |
| 2013-09-30 | 40.26% |
| 2013-06-30 | 39.94% |
| 2013-03-31 | 41.51% |
| 2012-12-31 | 40.25% |
| 2012-09-30 | 42.97% |
| 2012-06-30 | 40.73% |
| 2012-03-31 | 42.08% |
| 2011-12-31 | 38.85% |
| 2011-09-30 | 38.90% |
| 2011-06-30 | 41.72% |
| 2011-03-31 | 41.30% |
| 2010-12-31 | 41.74% |
| 2010-09-30 | 43.23% |
| 2010-06-30 | 9.56% |
| 2010-03-31 | 42.82% |
| 2009-12-31 | 42.55% |
| 2009-09-30 | 42.22% |
| 2009-06-30 | 44.03% |
| 2009-03-31 | 40.60% |
| 2008-12-31 | 38.84% |
| 2008-09-30 | 40.96% |
| 2008-06-30 | 41.89% |
| 2008-03-31 | 40.35% |
| 2007-12-31 | 41.47% |
| 2007-09-30 | 40.75% |
| 2007-06-30 | 42.25% |
| 2007-03-31 | 41.44% |
| 2006-12-31 | 42.71% |
| 2006-09-30 | 41.89% |
| 2006-06-30 | 42.77% |
| 2006-03-31 | 40.25% |
| 2005-12-31 | 42.47% |
| 2005-09-30 | 41.39% |
| 2005-06-30 | 43.11% |
| 2005-03-31 | 41.40% |
| 2004-12-31 | 42.54% |
| 2004-09-30 | 42.10% |
| 2004-06-30 | 43.13% |
| 2004-03-31 | 42.43% |
| 2003-12-31 | 41.96% |
| 2003-09-30 | 42.98% |
| 2003-06-30 | 41.10% |
| 2003-03-31 | 42.63% |
| 2002-12-31 | 42.55% |
| 2002-09-30 | 41.42% |
| 2002-06-30 | 41.48% |
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Daniel A. Carestio